Gallone, Annamaria
Riolo, Giorgia https://orcid.org/0009-0006-2075-3909
Ruggieri, Alessandra
Iannibelli, Eliana
Salerno, Franco
Nicolini De Gaetano, Lucia
Carnazzi, Alessandra
Maggi, Lorenzo
Gibertini, Sara
Article History
Received: 9 April 2025
Revised: 12 June 2025
Accepted: 14 June 2025
First Online: 23 June 2025
Declarations
:
: All authors have no relevant financial or non-financial interests to disclose related to this work. However, L. M. received funding for travel, meeting attendance, and advisory board participation from Sanofi Genzyme, Roche, Biogen, Amicus Therapeutics, Alexion Pharmaceuticals, Janssen, UCB, Lupin, and Argenx. He also received funding for fellowship from Biogen and Alexion Pharmaceuticals.
: Ethical approval was not required for this study as it is a retrospective analysis conducted within the routine clinical workflow. All data were collected as part of standard clinical care and were anonymized before analysis, in compliance with the current version of the Declaration of Helsinki as well as all national legal and regulatory requirements. Patients provided informed written consent.
: Patients provided written consent for publication.